Stromal progenitor cell modulation by thalidomide in the treatment of oral chronic graft-versus-host disease

Cytotherapy. 2018 May;20(5):755-758. doi: 10.1016/j.jcyt.2018.02.370. Epub 2018 Mar 23.

¹ Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Lindsay.Davies@ki.se.
² School of Dentistry, Cardiff University, Cardiff, United Kingdom.
³ Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Divisions of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
⁵ Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Keywords: graft-versus-host disease; oral mucosa; progenitor cell; stem cell; stroma; wound healing.

Publication types